USFDA APPLICATION NUMBER - 203414 / DOSAGE - TABLET;ORAL - EQ 12.5MG BASE;500MG
Active Ingredient/Active Moiety | ||
Ingredient Name | Basis of Strength | Strength |
---|---|---|
ALOGLIPTIN BENZOATE(UNII: EEN99869SC) (Alogliptin - UNII:JHC049LO86) | Alogliptin | 12.5mg | 12.5mg |
Metformin hydrochloride(UNII: 786Z46389E) (Metformin - UNII:9100L32L2N) | Metformin hydrochloride | 1000mg | 500mg |
Inactive Ingredients
Ingredient Name | Padagis Israel Pharmaceuticals Ltd |
---|---|
CROSPOVIDONE (120 .MU.M)(68401960MK) | |
ferric oxide yellow(EX438O2MRT) | |
HYPROMELLOSE 2910 (6 MPA.S)(0WZ8WG20P6) | |
magnesium stearate(70097M6I30) | |
mannitol(3OWL53L36A) | |
microcrystalline cellulose(OP1R32D61U) | |
POVIDONE, UNSPECIFIED(FZ989GH94E) | |
talc(7SEV7J4R1U) | |
titanium dioxide(15FIX9V2JP) |
LOOKING FOR A SUPPLIER?